Previous close | 11.73 |
Open | 13.15 |
Bid | 13.58 x 50000 |
Ask | 13.81 x 40000 |
Day's range | 13.15 - 13.15 |
52-week range | 10.08 - 78.30 |
Volume | |
Avg. volume | 27 |
Market cap | 1.482B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?